1. Home
  2. TECX vs DOGZ Comparison

TECX vs DOGZ Comparison

Compare TECX & DOGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • DOGZ
  • Stock Information
  • Founded
  • TECX 2019
  • DOGZ 2003
  • Country
  • TECX United States
  • DOGZ China
  • Employees
  • TECX N/A
  • DOGZ N/A
  • Industry
  • TECX
  • DOGZ Miscellaneous manufacturing industries
  • Sector
  • TECX
  • DOGZ Consumer Discretionary
  • Exchange
  • TECX Nasdaq
  • DOGZ Nasdaq
  • Market Cap
  • TECX 387.1M
  • DOGZ 399.0M
  • IPO Year
  • TECX 2018
  • DOGZ 2017
  • Fundamental
  • Price
  • TECX $23.51
  • DOGZ $15.98
  • Analyst Decision
  • TECX Strong Buy
  • DOGZ
  • Analyst Count
  • TECX 5
  • DOGZ 0
  • Target Price
  • TECX $79.00
  • DOGZ N/A
  • AVG Volume (30 Days)
  • TECX 230.2K
  • DOGZ 184.2K
  • Earning Date
  • TECX 08-07-2025
  • DOGZ 03-31-2025
  • Dividend Yield
  • TECX N/A
  • DOGZ N/A
  • EPS Growth
  • TECX N/A
  • DOGZ N/A
  • EPS
  • TECX N/A
  • DOGZ N/A
  • Revenue
  • TECX N/A
  • DOGZ $20,258,926.00
  • Revenue This Year
  • TECX N/A
  • DOGZ N/A
  • Revenue Next Year
  • TECX N/A
  • DOGZ N/A
  • P/E Ratio
  • TECX N/A
  • DOGZ N/A
  • Revenue Growth
  • TECX N/A
  • DOGZ 46.16
  • 52 Week Low
  • TECX $13.70
  • DOGZ $7.16
  • 52 Week High
  • TECX $61.07
  • DOGZ $58.50
  • Technical
  • Relative Strength Index (RSI)
  • TECX 56.50
  • DOGZ 71.62
  • Support Level
  • TECX $21.31
  • DOGZ $7.16
  • Resistance Level
  • TECX $23.12
  • DOGZ $8.50
  • Average True Range (ATR)
  • TECX 1.53
  • DOGZ 1.28
  • MACD
  • TECX 0.13
  • DOGZ 1.26
  • Stochastic Oscillator
  • TECX 71.85
  • DOGZ 96.78

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

Share on Social Networks: